Jessica L Goldhirsh
Biographic Data
| ID | 7961993 |
|---|---|
| NAME | Jessica L Goldhirsh |
| GIVEN NAMES | Jessica L |
| FAMILY NAME | Goldhirsh |
| SIGNATURE | GOLDHIRSH J L |
| AFFILIATIONS | Geisinger Commonwealth School of Medicine |
| ORCID | 0000-0002-1825-2666 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States
Despite limited evidence suggesting that citalopram and escitalopram have any meaningful differences in therapeutic or adverse effects, there exists a noticeable decline in the use of citalopram that cooccurred with an increase in escitalopram prescribing, consistent with our hypothesis. Moreover, among these general pharmacoepidemiologic trends exists significant geographic variability. There was disproportionate spending (relative to their use)…
National patterns of paroxetine use among US Medicare patients from 2015–2020
Despite the American Geriatrics Society's prohibition against paroxetine use in older adults and many effective treatment alternatives, paroxetine was still commonly used in the US in this population, especially in Kentucky and North Dakota and by neuropsychiatry and geriatric medicine. These findings provide information on the specialty types and states where education and policy reform would likely have the greatest impact on improving adherenc…
No prominent works on this page.
National patterns of paroxetine use among US Medicare patients from 2015–2020
Despite the American Geriatrics Society's prohibition against paroxetine use in older adults and many effective treatment alternatives, paroxetine was still commonly used in the US in this population, especially in Kentucky and North Dakota and by neuropsychiatry and geriatric medicine. These findings provide information on the specialty types and states where education and policy reform would likely have the greatest impact on improving adherenc…
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States
Despite limited evidence suggesting that citalopram and escitalopram have any meaningful differences in therapeutic or adverse effects, there exists a noticeable decline in the use of citalopram that cooccurred with an increase in escitalopram prescribing, consistent with our hypothesis. Moreover, among these general pharmacoepidemiologic trends exists significant geographic variability. There was disproportionate spending (relative to their use)…
Antidepressant (2 works) · Anxiety (2 works) · Medical prescription (2 works) · Medicare Part D (2 works) · Medicine (2 works) · Psychiatry (2 works) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 work) · Blood Pressure and Hypertension Studies (1 work) · Citalopram (1 work) · Health care (1 work)